Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01955226 · ClinicalTrials.gov registry record · NA
CHG Dressings in Children With Central Lines
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01955226 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 16 participants.
The verdict
NCT01955226, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the number of unscheduled central catheter dressing changes compared to standard clear Tegaderm IV dressing in pediatric patients between the ages of 2 months to 18 years with central venous access. Secondarily, we will monitor contact skin irritation and central line associated blood stream infections.
Interventions
- OTHER Tegaderm CHG clear dressing
- OTHER Standard clear Tegaderm dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01955226
The ClinicalTrials.gov registry entry for NCT01955226 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tegaderm CHG clear dressing is the first listed.
NCT01955226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01955226 about?
NCT01955226 is a clinical study titled "CHG Dressings in Children With Central Lines". The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the number of unscheduled central catheter dressing changes compared to standard clear Tegaderm IV dressing in pediatric patients between the ages of 2 months to 18 years with central venous access. Secondarily, we...
What is the current status of trial NCT01955226?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2014-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01955226?
The interventions under investigation include: Tegaderm CHG clear dressing (OTHER), Standard clear Tegaderm dressing (OTHER).
Who is sponsoring clinical trial NCT01955226?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.